Exact Sciences
EXAS
#1124
Rank
C$27.87 B
Marketcap
C$146.01
Share price
0.00%
Change (1 day)
132.70%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): C-$7.63

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is C-$7.40. In 2024 the company made an earnings per share (EPS) of C-$7.75.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$7.63-1.56%
2024C-$7.75
2022C-$4.932.31%
2021C-$4.82-38.54%
2020C-$7.84692.96%
2019C-$0.99-50.69%
2018C-$2.0044%
2017C-$1.39-39.39%
2016C-$2.30-2.94%
2015C-$2.3737.1%
2014C-$1.7379.71%
2013C-$0.96-21.59%
2012C-$1.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.87-138.82%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
C$1.17-115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
C$0.47-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
C-$6.03-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$70.84 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA